BBIO vs TWLO · rev $221.9M vs P/E 1087, rev $4.46B
BridgeBio Pharma Inc (BBIO) versus Twilio Inc (TWLO) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Twilio Inc (TWLO) is a software - infrastructure company listed on US.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported TWLO revenue for 2024-12-31 was $4.46B. Net income was -$109.4M. Revenue was up 7.3% from 2023-12-31 to 2024-12-31. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
BBIO currently screens at market cap $13.24B. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
Not investment advice. Open the BBIO and TWLO stock pages for the full models.
Not investment advice.